Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Terrie Curran Insider Profile
4 Followers
Terrie Curran, PRES., GLBL INFLAM. AND IMMUN. at Celgene, holds 381.57K shares in Phathom Pharmaceuticals (Ticker: PHAT), holds 18.83K shares in Arcutis Biotherapeutics (Ticker: ARQT), holds 0.00 shares in Myovant Sciences (Ticker: MYOV).
Terrie Curran Celgene (CELG)PRES., GLBL INFLAM. AND IMMUN.
Celgene (CELG)
PRES., GLBL INFLAM. AND IMMUN.
Ranked #10,784 out of 99,335 Corporate Insiders
Profitable Transactions
5 out of 5 Profitable Transactions
Average Return
+32.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Terrie Curran holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 23, 2021 - Mar 23, 2022
Return:+66.80%
The most profitable trade made by Terrie Curran
Terrie Curran's Trading History
Celgene
Nov 22, 2019
―
Uninformative Buy
―
$567.07K
Myovant Sciences
Mar 10, 2023
―
Uninformative Sell
―
$0.00
Phathom Pharmaceuticals
Jul 17, 2024
President & CEO, Director
Uninformative Sell
396.70K
$5.00M
Arcutis Biotherapeutics
Jun 18, 2024
Director
Uninformative Buy
―
$204.07K
List of latest transactions for each holding click on a transaction to see Terrie Curran's performance on stock
You May Also Like
Terrie Curran insider profile FAQ
What is the percentage of profitable transactions made by Terrie Curran?
The percentage of profitable transactions made by Terrie Curran is 100%.
What is the average return per transaction made by Terrie Curran?
The average return per transaction made by Terrie Curran is 32.10%.
What stocks does Terrie Curran hold?
Terrie Curran holds: CELG, MYOV, PHAT, ARQT stocks.
What was Terrie Curran’s latest transaction?
Terrie Curran latest transaction was an Uninformative Sell of $396.70K.
What was Terrie Curran's most profitable transaction?
Terrie Curran’s most profitable transaction was an Informative Sell of PHAT stock on March 23, 2021. The return on the trade was 66.80%.
What is Terrie Curran's role in Celgene?
Terrie Curran's role in Celgene is PRES., GLBL INFLAM. AND IMMUN..
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.